Search Within

David Scheinberg

  1. "Martin Graham"
Formats
  1. Journal Article (8)
  2. Meeting Abstract (3)
  3. Conference Paper (2)
Groups
  1. Adult Leukemia (13)
  2. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (13)
  3. Center for Hematologic Malignancies (13)
  4. Center for Molecular Imaging and Biotechnology (CMIB) (13)
  5. Department of Medicine (13)
  6. GSK Faculty (13)

More Groups

People
  1. Martin Graham (13)
  2. Steven Larson (12)
  3. Chaitanya Divgi (11)
  4. Ronald Finn (9)
  5. George Sgouros (7)
  6. Andrew Scott (6)

More People

Years
  1. 1996 (1)
  2. 1994 (4)
  3. 1993 (5)
  4. 1991 (2)
  5. 1990 (1)
Publications
  1. Journal of Nuclear Medicine (5)
  2. Journal of Clinical Oncology (4)
  3. Antibody, Immunoconjugates, and Radiopharmaceuticals (1)
  4. Blood (1)
  5. Cancer (1)
  6. Nuclear Medicine and Biology (1)
Publishers
  1. Society of Nuclear Medicine (5)
  2. American Society of Clinical Oncology (4)
  3. American Society of Hematology (1)
  4. Elsevier Science Inc. (1)
  5. Mary Ann Liebert, Inc. (1)
  6. Wiley Blackwell (1)

Results (13)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Bone marrow dosimetry: Regional variability of marrow-localizing antibody
    Journal Article

    Sgouros, G.; Jureidini, I. M.; Scott, A. M.; Graham, M. C.; Larson, S. M.; Scheinberg, D. A.
    Journal of Nuclear Medicine (1996)

    Fulltext@MSK | Save
  • Clinical implementation of new region-specific S-values for marrow dosimetry: Dose distribution vs mean marrow dose in radioimmunotherapy of leukemia
    Meeting Abstract

    Sgouros, G.; Stabin, M. G.; Jureidini, I. M.; Scott, A. S.; Graham, M. C.; Larson, S. M.; Scheinberg, D. A.; Eckerman, K. F.
    Journal of Nuclear Medicine (1994)

    Fulltext@MSK | Save
  • Current status of radioimmunotherapy
    Journal Article

    Larson, S. M.; Divgi, C. R.; Scott, A.; Sgouros, G.; Graham, M. C.; Kostakoglu, L.; Scheinberg, D.; Cheung, N. K. V.; Schlom, J.; Finn, R. D.
    Nuclear Medicine and Biology (1994)

    Fulltext@MSK | Save
  • Murine and humanized constructs of monoclonal antibody M195 (anti‐CD33) for the therapy of acute myelogenous leukemia
    Conference Paper

    Caron, P. C.; Schwartz, M. A.; Co, M. S.; Queen, C.; Finn, R. D.; Graham, M. C.; Divgi, C. R.; Larson, S. M.; Scheinberg, D. A.
    Wiley Blackwell (1994)

    Fulltext@MSK | Save
  • A phase 1B trial of humanized monoclonal antibody M195 (anti-CD33) in myeloid leukemia: Specific targeting without immunogenicity
    Journal Article

    Caron, P. C.; Jurcic, J. G.; Scott, A. M.; Finn, R. D.; Divgi, C. R.; Graham, M. C.; Jureidini, I. M.; Sgouros, G.; Tyson, D.; Old, L. J.; more...
    Blood (1994)

    Fulltext@MSK | Save
  • Clinical implementation of modeling-based radioimmunotherapy treatment planning: I-131-M195 antibody against chronic myelogenous leukemia
    Meeting Abstract

    Sgouros, G.; Graham, M. C.; Scott, A.; Caron, P. C.; Divgi, C. R.; Finn, R.; Carabasi, M.; Larson, S. M.; Scheinberg, D. A.
    Journal of Nuclear Medicine (1993)

    Fulltext@MSK | Save
  • I-131 M195 (anti-CD33) radioimmunotherapy trials in patients with myeloid leukemias
    Meeting Abstract

    Larson, S. M.; Scott, A. M.; Divgi, C. R.; Finn, R. D.; Graham, M. C.; Sgouros, G.; Scheinberg, D. A.
    Journal of Nuclear Medicine (1993)

    Fulltext@MSK | Save
  • Modeling and dosimetry of monoclonal antibody M195 (anti-CD33) in acute myelogenous leukemia
    Journal Article

    Sgouros, G.; Graham, M. C.; Divgi, C. R.; Larson, S. M.; Scheinberg, D. A.
    Journal of Nuclear Medicine (1993)

    Fulltext@MSK | Save
  • Phase I dose-escalation trial of iodine 131-labeled monoclonal antibody OKB7 in patients with non-Hodgkin's lymphoma
    Journal Article

    Czuczman, M. S.; Straus, D. J.; Divgi, C. R.; Graham, M.; Garin-Chesa, P.; Finn, R.; Myers, J.; Old, L. J.; Larson, S. M.; Scheinberg, D. A.
    Journal of Clinical Oncology (1993)

    Fulltext@MSK | Save
  • Dose-escalation trial of M195 labeled with iodine 131 for cytoreduction and marrow ablation in relapsed or refractory myeloid leukemias
    Journal Article

    Schwartz, M. A.; Lovett, D. R.; Redner, A.; Finn, R. D.; Graham, M. C.; Divgi, C. R.; Dantis, L.; Gee, T. S.; Andreeff, M.; Old, L. J.; more...
    Journal of Clinical Oncology (1993)

    Fulltext@MSK | Save